| ACRIX | HCYAX | ACRIX / HCYAX | |
| Total Expense Ratio | 1.18 | 1.30 | 91% |
| Annual Report Gross Expense Ratio | 1.18 | 1.52 | 78% |
| Fund Existence | 9 years | 12 years | - |
| Gain YTD | 9.627 | 6.701 | 144% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000000 | 2500 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.37B | 128M | 1,066% |
| Annual Yield % from dividends | 0.48 | 3.66 | 13% |
| Returns for 1 year | -2.20 | 6.06 | -36% |
| Returns for 3 years | 31.11 | 24.76 | 126% |
| Returns for 5 years | 26.87 | 29.77 | 90% |
| Returns for 10 years | N/A | 60.12 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FCDCX | 33.48 | 0.86 | +2.64% |
| Fidelity Advisor Stock Selector Sm Cp C | |||
| PHSZX | 51.78 | 1.04 | +2.05% |
| PGIM Jennison Health Sciences Z | |||
| UIVNX | 12.78 | 0.19 | +1.51% |
| MFS Intrinsic Value R2 | |||
| RRGTX | 7.36 | 0.09 | +1.24% |
| DWS RREEF Global Real Estate Secc S | |||
| LICVX | 18.20 | 0.19 | +1.05% |
| Lord Abbett International Equity R6 | |||